Biotechnology - UK

Filter

Current filters:

UK

Popular Filters

1 to 25 of 106 results

Jeff Barrett named founding director of Centre for Therapeutic Target Validation with GSK and Wellcome

Jeff Barrett named founding director of Centre for Therapeutic Target Validation with GSK and Wellcome

02-03-2015

Jeffrey Barrett has been appointed the founding director for the Centre for Therapeutic Target Validation,…

BiotechnologyBoardroomCentre for Therapeutic Target ValidationGlaxoSmithKlineUK

AstraZeneca inks deal with Orca for autoimmune disease drugs

AstraZeneca inks deal with Orca for autoimmune disease drugs

25-02-2015

Anglo-Swedish pharma major AstraZeneca and Orca Pharmaceuticals, a UK based biopharmaceutical company,…

AstraZenecaBiotechnologyImmunologicalsInflammatory diseasesLicensingOrca PharmaceuticalsRespiratory and PulmonaryUK

UK doctors call for approval of off-label use of Avastin for wet-AMD

UK doctors call for approval of off-label use of Avastin for wet-AMD

25-02-2015

Doctors in the UK are calling on health ministers and NHS England to intervene to make Swiss pharma giant…

AvastinBiotechnologyHealthcareLucentisNovartisOphthalmicsPricingRegulationRocheUK

Kymab appoints Anne Hyland as chief financial officer

Kymab appoints Anne Hyland as chief financial officer

19-02-2015

Kymab, a pharma company based in Cambridge, UK, focusing on monoclonal antibodies, has appointed Anne…

BiotechnologyBoardroomKymabPharmaceuticalUK

Cell Medica starts commercial cell therapy manufacture in Germany

19-02-2015

UK-based cellular immunotherapy company Cell Medica has announced the start of commercial cell therapy…

BiotechnologyCell MedicaCytovir CMVOncologyProductionUK

NICE final draft guidance does not recommend pomalidomide for blood cancer

NICE final draft guidance does not recommend pomalidomide for blood cancer

13-02-2015

The England medical costs watchdog the National Institute for Health and Care excellence (NICE) has issued…

BiotechnologyCelgene CorpImnovidOncologypomalidomidePricingRegulationUK

Celgene's Abraxane recommended by Scottish Medicines Consortium

Celgene's Abraxane recommended by Scottish Medicines Consortium

10-02-2015

The Scottish Medicines Consortium has decided to recommend Abraxane (paclitaxel) in combination with…

AbraxaneBiotechnologyCelgene CorpOncologyRegulationUK

Gilead to increase investment in UK

09-02-2015

London's status as a leading center for the life sciences, financial and digital industries has attracted…

BiotechnologyFinancialGilead SciencesUK

Cell Therapy raises record-breaking crowdfunding for stem cell drug

09-02-2015

UK biotech company Cell Therapy has raised over £691,000 ($1 million) through crowdfunding on Crowdcube…

BiotechnologyCardio-vascularCell therapyCell Therapy LtdFinancialHeartcelUK

Motif Bio to list on AIM to progress novel antibiotic

Motif Bio to list on AIM to progress novel antibiotic

02-02-2015

Motif Bio has announced its intention to list on the alternative Investment Market to raise at least…

Antibiotics and Infectious diseasesBiotechnologyFinancialMotif BiosciencesUK

AstraZeneca to employ CRISPR, a new technique for drug discovery

AstraZeneca to employ CRISPR, a new technique for drug discovery

29-01-2015

Anglo-Swedish pharma major AstraZeneca has announced a research program to develop new medicines that…

AstraZenecaBiologyBiotechnologyResearchUK

First UK NICE highly specialized technologies guidance recommends Soliris

First UK NICE highly specialized technologies guidance recommends Soliris

28-01-2015

England’s health costs watchdog the National Institute for Health and care Excellence has today issued…

Alexion PharmaceuticalsBiotechnologyHematologyPricingRare diseasesRegulationSolarisUK

Syncona and UCL Business form cancer immunotherapy company Autolus

Syncona and UCL Business form cancer immunotherapy company Autolus

22-01-2015

Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University…

BiologyBiotechnologyOncologyResearchUK

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

19-01-2015

UK-based C4X Discovery Holdings has entered into a research agreement with drug discovery alliance Evotec.

BiotechnologyC4X DiscoveryEvotec AGLicensingNeurologicalUK

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

16-01-2015

In final draft guidance issued today, England health costs watchdog the National Institute for Health…

Anti-viralsBiotechnologyGilead SciencesJanssenJohnson & JohnsonOlysioPricingRegulationSovaldiUK

Cost to NHS of Provenge too high to be recommended, says NICE

13-01-2015

England’s health care cost watchdog the National Institute for Health and Care Excellence (NICE) has…

BiotechnologyDendreonOncologyPricingProvengeRegulationUK

NICE opens consultation on Millennium’s Crohn’s drug Entyvio

23-12-2014

In draft guidance issued today, UK health costs watchdog the National Institute for Health and Care Excellence…

BiotechnologyEntyvioGastro-intestinalsMillennium PharmaceuticalsPricingRegulationTakeda PharmaceuticalUK

PDS Biotechnology appoints Richard Sykes executive chairman of its board of directors

PDS Biotechnology appoints Richard Sykes executive chairman of its board of directors

18-12-2014

Immunotherapeutic company PDS Biotechnology has made Richard Sykes executive chairman of its board of…

BiotechnologyBoardroomImmunologicalsPDS BiotechnologyUK

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

16-12-2014

UK-based antibody therapeutics specialist Crescendo Biologics has received another equity investment…

BiotechnologyBusiness FinanceCrescendo BiologicsOncologyUK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

16-12-2014

A new biomedical laboratory, the Biomedical Innovation Hub (the BioHub) has opened in Birmingham, UK.

BiotechnologyBirminghamResearchUKUnited Kingdom

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

Valneva and BliNK Therapeutics launch new biotech company

Valneva and BliNK Therapeutics launch new biotech company

12-12-2014

France-based biotech firm Valneva and privately-held UK company BliNK Therapeutics have created a private…

BiotechnologyBliNK BiomedicalBliNK TherapeuticsFinancialFranceMergers & AcquisitionsUKValneva

Celgene appoints Wim Souverijns as vice president general manager for UK and Ireland

Celgene appoints Wim Souverijns as vice president general manager for UK and Ireland

11-12-2014

US biotech company Celgene has appointed Wim Souverijns as vice president general manager for the UK…

BiotechnologyBoardroomCelgene Corp.UKUK & Ireland

NICE now proposes to recommend Stelara for psoriatic arthritis

NICE now proposes to recommend Stelara for psoriatic arthritis

09-12-2014

UK health cost watchdog, the National Institute for Health and Care Excellence (NICE) has opened a consultation…

Anti-Arthritics/RheumaticsBiotechnologyInflammatory diseasesJanssenJohnson & JohnsonPricingRegulationStelaraUK

1 to 25 of 106 results

COMPANY SPOTLIGHT

Menarini

Back to top